Time to TEAM: exemestane, or tamoxifen then exemestane?

Lancet. 2011 Jan 22;377(9762):280-1. doi: 10.1016/S0140-6736(11)60073-1.
No abstract available

Publication types

  • Kommentar

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy
  • Androstadienes / therapeutic use*
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy*
  • Disease-Free Survival
  • Female
  • Humans
  • Postmenopause
  • Randomized Controlled Trials as Topic*
  • Receptors, Estrogen / metabolism
  • Receptors, Progesterone / metabolism
  • Tamoxifen / therapeutic use*
  • Translational Research, Biomedical

Substances

  • Androstadienes
  • Antineoplastic Agents, Hormonal
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Tamoxifen
  • exemestane